Infinite Epigenetics Acquires Tally Health, Expanding Longevity & Diagnostics Platform

A massive combined dataset and amplified diagnostics capabilities position the company to push epigenetic testing to the forefront of personalized healthspan solutions

Tally Health is entering a new chapter, as the longevity startup has been acquired by Infinite Epigenetics, a biological age and genetic testing company, bringing together the two brands’ shared mission of extending the human healthspan.

The deal folds Tally’s science into Infinite Epigenetics’ diagnostic testing and aging solutions to create a vertically integrated platform, which features advanced epigenetic insights and personalized interventions like longevity-focused supplements designed to boost healthspan.

The brands are also combining their massive proprietary datasets, creating one of the largest and most diverse private adult DNA methylation datasets, as well as intellectual property. The collaboration could advance the role of epigenetics, potentially propelling scientific advancements of next-generation diagnostics and interventions, as well as how epigenetics impacts research, lifestyle shifts and mainstream healthcare.

While Tally will function under Infinite Epigenetics, it will maintain its position as a stand-alone consumer brand, with Melanie Goldey remaining CEO of Tally Health, leading the consumer business, as Dr. Matthew Dawson leads as CEO of Infinite Epigenetics and its subsidiary, TruDiagnostic.

“We believe epigenetics will underpin the next generation of medical diagnostics, shifting healthcare from reactive treatment to proactive, data-driven prevention,” said Dawson. 

“Our ambition is to build a category-defining diagnostics platform,” he continued. “By combining our scientific infrastructure, proprietary data, and clinical capabilities with Tally Health’s consumer reach, we can accelerate the adoption of epigenetics across healthcare — from research and clinical settings to population-scale applications.”

The transaction marks another contribution to Infinite Epigenetics’ expanding portfolio spanning diagnostics, data and consumer health, with numerous accredited partnerships amplifying its research. Its subsidiary TruDiagnostic, for instance, is backed by more than 115 research partnerships with top institutions including Harvard, Yale, Duke and Stanford.

“From day one, Tally Health was built to take the most advanced science of aging and make it actionable for everyday people,” said Goldey. “Joining Infinite Epigenetics allows us to dramatically accelerate that mission by combining best-in-class data, scientific rigor, and consumer experience to deliver a truly end-to-end longevity platform. Together, we have the opportunity to redefine how people engage with their health and aging.”

Tally is known for its TallyAge Test, an epigenetic age test delivered through an at-home cheek swab, alongside a line of science-backed supplements and personalized recommendations meant to target key drivers of aging.

“Epigenetics is one of the most powerful tools we have to understand the biological drivers of aging and disease,” said Tally Health co-founder and Professor of Genetics at Harvard Medical School, Dr. David Sinclair. “Given that our health is our most important asset, I’m excited to see technologies from my Harvard lab being translated into real-world applications to improve health. This combination brings together the scale of data, scientific rigor, and consumer reach needed to accelerate that impact.”

The brand is a favorite among celebrities, backed by investors such as Pedro Pascal, Zac Efron, Shonda Rimes, Kevin Hart, Whitney Cummings, John Legend and Chrissy Teigen, raising $10 million in 2023.

Last year Tally also partnered with the Jennifer Aniston-backed longevity fitness brand Pvolve to launch an exclusive low-impact functional training program, in which participants also received personalized insights from the TallyAge epigenetic test. 

The two brands took their relationship to the next level soon after, unveiling “The Longevity Formula,” a wellness program designed to help individuals move smarter and age better by supporting energy, strength, and cellular health through targeted interventions across fitness, supplements, and biological testing.

Financial details of the acquisition were not disclosed.